@3speeders @NorthBristolNHS @BladderCancerUK Good luck with your treatment!
#BCGUnresponsive
IBCG - “a clinically meaningful complete response rate for CIS at least 50% at 6m, 30% at 12m..is recommended”
#HIVEC in BCGU
70% CR @ 3m
>50% CR @ 6m
STILL 50% CR @ 12m
https://tinyurl.com/5arewevc
#BladderCancer
#BladderCancerAwarenessMonth
Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
To provide recommendations on appropriate clinical trial designs in non–muscle-invasive bladder cancer (NMIBC) based on current literature and exper...
tinyurl.com
🇵🇱First successful Combat PRS+A-HIPEC Cases after CRS done at the Lower Silesian Oncology Institute in Wroclaw last week🇵🇱 with our local partner Meden-Inmed Sp. z o.o.!
Many thanks to Prof.Dr.Bebenek and his team for the opportunity.@CombatCancer @ESSOnews @operarelcancer #HIPEC
Great results from our friends @DukeUrology on the use of HIVEC in the USA.
“HIVEC is a safe and well-tolerated substitute for BCG during global shortages”
👏🏻👏🏻👏🏻 @DominicGrimberg @BrantInman
#BladderCancer #Cancer #HIVEC
https://www.sciencedirect.com/science/article/abs/pii/S1078143920306542
Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC
"Our study demonstrates the feasibility of HIVEC MMC and suggests it is a reasonable substitute for BCG during global shortages," says urologist Scott...
www.urologytimes.com
Great results from our friends @DukeUrology on the use of HIVEC in the USA.
“HIVEC is a safe and well-tolerated substitute for BCG during global shortages”
👏🏻👏🏻👏🏻 @DominicGrimberg @BrantInman
#BladderCancer #Cancer #HIVEC
https://www.sciencedirect.com/science/article/abs/pii/S1078143920306542
Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC
"Our study demonstrates the feasibility of HIVEC MMC and suggests it is a reasonable substitute for BCG during global shortages," says urologist Scott...
www.urologytimes.com
More great news for Combat’s #HIVEC treatment of #bladdercancer from @BrantInman and team at @ASCO meeting.
“Bladder pressure dramatically improves the extent of gemcitabine penetration into the bladder wall”
https://meetinglibrary.asco.org/record/194854/abstract
Many thanks to the team @DukeUrology 👏🏻👏🏻👏🏻
Excellent to hear this. So happy our machine is working to treat patients in Bristol. @CombatCancer #HIVEC #bladdercancer @NorthBristolNHS
Here I go again, this treatment is amazing and I’m so grateful to @NorthBristolNHS #urology for providing this ‘maintenance’ #bladdercancer @CombatCancer @Actionbladderca
Here I go again, this treatment is amazing and I’m so grateful to @NorthBristolNHS #urology for providing this ‘maintenance’ #bladdercancer @CombatCancer @Actionbladderca
@alarjosan @HUReinaSofia @IMIBIC @GECOP_ @operarelcancer @SPeritoneum @aecirujanos @ESSOnews @Hospital_FJD Congrats @alarjosan and team!
Proud to be working with you!
👏🏻👏🏻👏🏻👏🏻👏🏻
Yet another publication showing #HIVEC to be a viable, safe and well tolerated treatment for BCG failure patients with both #mitomycin and #epirubicin.
Thanks to @francescok86 for his great work.
#BladderCancer #Hyperthermia #BCG
https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/125687-outcomes-and-complications-of-hyperthermic-intravesical-chemotherapy-using-mitomycin-c-or-epirubicin-for-patients-with-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-treatment-failure.html
Yet another publication showing #HIVEC to be a viable, safe and well tolerated treatment for BCG failure patients with both #mitomycin and #epirubicin.
Thanks to @francescok86 for his great work.
#BladderCancer #Hyperthermia #BCG
https://www.urotoday.com/recent-abstracts/urologic-oncology/bladder-cancer/125687-outcomes-and-complications-of-hyperthermic-intravesical-chemotherapy-using-mitomycin-c-or-epirubicin-for-patients-with-non-muscle-invasive-bladder-cancer-after-bacillus-calmette-guerin-treatment-failure.html
📢NEXT WEEK📢Prophylactic #peritoneal Management of High-Risk #ColonCancer
🗓️3 NOV-18.30 CEST
🗣Dr @AndreasBrandl8, Dr @alarjosan, Dr Diane Goéré & Dr Pieter Tanis ➡️https://lnkd.in/gNsACYN
#HIPEC #PeritonealMetastases #colorectalsurgery #colorectalcancer @CombatCancer
They don’t do an emoji for HIPEC with agitation bubbles of CO2.
Is this close enough @alarjosan?
🛁🛁🛁🛁🛁
There are some great posters @ #BLADDR18 #HIVEC pic.twitter.com/bDnahheB4s
— Combat Medical #HIVEC #HIPEC (@CombatCancer) September 20, 2018
